In a move designed to provide continued access to remote healthcare services for millions of Medicare beneficiaries, lawmakers approved a three-month extension of expanded telemedicine coverage, set to last until March 31, The New York Times reported Jan. 6. 

CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model. 

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder. 

Eli Lilly is intervening in a lawsuit filed by a trade group representing compounding pharmacies, aiming to block the FDA's determination that the shortage of its GLP-1 medications, Mounjaro and Zepbound, has ended. 

Of the hundreds of drugs that entered the U.S. market in 2024, GoodRx has named 19 of them as the most notable. 

The FDA has finalized a rule that establishes requirements for nonprescription drug products with additional conditions for nonprescription use (ACNU). 

Pharmacy benefit managers are coming under growing scrutiny as policymakers push for reforms to address their role in rising drug prices, The Wall Street Journal reported Dec. 30. 

Samaritan Health Services will open a neighborhood pharmacy at Samaritan North Lincoln Hospital in Lincoln City, Ore., on Jan. 6. 

Here are five drug recalls the FDA reported in December: 

President-elect Donald Trump's proposal to increase tariffs on products from Mexico, Canada and China could increase pharmaceutical costs and disrupt supply, The Hill reported Dec. 31.